Walleye Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-355,700
| Closed | -$46.9M | – | 4836 |
|
|
2025
Q1 | $46.9M | Buy |
+355,700
| New | +$44.3M | 0.11% | 178 |
|
|
2024
Q3 | – | Sell |
-2,900
| Closed | -$199K | – | 4686 |
|
|
2024
Q2 | $199K | Sell |
2,900
-4,300
| -60% | -$298K | ﹤0.01% | 3095 |
|
|
2024
Q1 | $498K | Buy |
7,200
+7,000
| +3,500% | +$481K | ﹤0.01% | 2787 |
|
|
2023
Q4 | $14.3K | Buy |
+200
| New | +$11.5K | ﹤0.01% | 4555 |
|
|
2023
Q2 | – | Sell |
-9,100
| Closed | -$493K | – | 5299 |
|
|
2023
Q1 | $493K | Sell |
9,100
-33,100
| -78% | -$1.6M | ﹤0.01% | 2815 |
|
|
2022
Q4 | $2.23M | Sell |
42,200
-13,600
| -24% | -$682K | 0.01% | 1595 |
|
|
2022
Q3 | $2.6M | Buy |
55,800
+46,600
| +507% | +$2.43M | 0.01% | 1502 |
|
|
2022
Q2 | $525K | Sell |
9,200
-4,200
| -31% | -$238K | ﹤0.01% | 2871 |
|
|
2022
Q1 | $820K | Sell |
13,400
-15,000
| -53% | -$779K | ﹤0.01% | 2417 |
|
|
2021
Q4 | $1.49M | Sell |
28,400
-3,100
| -10% | -$130K | ﹤0.01% | 1889 |
|
|
2021
Q3 | $1.17M | Sell |
31,500
-100,300
| -76% | -$3.49M | ﹤0.01% | 2046 |
|
|
2021
Q2 | $5.38M | Buy |
131,800
+121,600
| +1,192% | +$4.49M | 0.02% | 761 |
|
|
2021
Q1 | $346K | Sell |
10,200
-15,300
| -60% | -$531K | ﹤0.01% | 3082 |
|
|
2020
Q4 | $811K | Sell |
25,500
-28,500
| -53% | -$749K | ﹤0.01% | 2202 |
|
|
2020
Q3 | $1.39M | Buy |
+54,000
| New | +$1.23M | 0.01% | 1404 |
|
|
2020
Q2 | – | Sell |
-500
| Closed | -$8K | – | 4686 |
|
|
2020
Q1 | $8K | Sell |
500
-11,200
| -96% | -$243K | ﹤0.01% | 3756 |
|
|
2019
Q4 | $401K | Sell |
11,700
-24,300
| -68% | -$292K | ﹤0.01% | 2583 |
|
|
2019
Q3 | $269K | Buy |
36,000
+35,900
| +35,900% | +$344K | ﹤0.01% | 2692 |
|
|
2019
Q2 | $1K | Sell |
100
-21,300
| -100% | -$273K | ﹤0.01% | 3956 |
|
|
2019
Q1 | $261K | Buy |
21,400
+18,600
| +664% | +$238K | ﹤0.01% | 2826 |
|
|
2018
Q4 | $32K | Buy |
+2,800
| New | +$45.2K | ﹤0.01% | 4252 |
|
Other funds holding ITCI
Walleye Trading's ITCI Position: Q2 2025 in Review
Walleye Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 8,000 shares — an estimated $1.06M sold.
Walleye Trading first reported a position in ITCI in Q2 2017 and held it in 18 quarters. The position peaked at $1.74M in Q4 2019. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Walleye Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 8,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.06M.
- Walleye Trading first reported a position in Intra-Cellular Therapies Inc. in Q2 2017 and held it in 18 quarters.
- Walleye Trading's Intra-Cellular Therapies Inc. position peaked at $1.74M in Q4 2019.
- 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.